Dimethylacetamide → HCID 25119787, compound
Reaction equation
[CH3:1][O:2][C:3]([C:5]1[N:6]([C:27]2[CH:32]=[CH:31][CH:30]=[CH:29][CH:28]=2)[C:7]2[C:12]([C:13](=[O:25])[C:14]=1[CH2:15][C:16]1[CH:17]=[N:18][C:19]([C:22](O)=[O:23])=[CH:20][CH:21]=1)=[CH:11][CH:10]=[C:9]([CH3:26])[N:8]=2)=[O:4].F[P-](F)(F)(F)(F)F.N1(O[P+](N(C)C)(N(C)C)[N:51]([CH3:53])[CH3:52])C2C=CC=CC=2N=N1.CC(N(C)C)=O.CCN(C(C)C)C(C)C>C1COCC1.O.CCOC(C)=O>[CH3:1][O:2][C:3]([C:5]1[N:6]([C:27]2[CH:28]=[CH:29][CH:30]=[CH:31][CH:32]=2)[C:7]2[C:12]([C:13](=[O:25])[C:14]=1[CH2:15][C:16]1[CH:17]=[N:18][C:19]([C:22](=[O:23])[N:51]([CH3:53])[CH3:52])=[CH:20][CH:21]=1)=[CH:11][CH:10]=[C:9]([CH3:26])[N:8]=2)=[O:4]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 3
Procedure
To 3-(6-carboxy-pyridin-3-ylmethyl)-7-methyl-4-oxo-1-phenyl-1,4-dihydro-[1,8]naphthyridine-2-carboxylic acid methyl ester (0.095 g) in THF (6 mL) was added BOP (0.11 g), followed by DMA (0.15 mL, 2M in THF) and Hunig's Base (ethyl-diisopropylamine) (0.042 mL). Solids began to precipitate: DCM was added until all solids dissolved, and a homogenous reaction mixture was obtained. The mixture was stirred at RT for 1 h, then an additional aliquot of BOP, Hunig's base, and DMA added, and the mixture stirred at RT overnight. The product was worked up with EtOAc and H2O, washed with NaHCO3 (aq) and H2O, and dried over MgSO4. The product was concentrated, applied to a silica gel column with EtOAc, and eluted with EtOAc/MeOH, and concentrated to yield 3-(6-dimethylcarbamoyl-pyridin-3-ylmethyl)-7-methyl-4-oxo-1-phenyl-1,4-dihydro[1,8]naphthyridine-2-carboxylic acid methyl ester (compound 103) (80 mg) as a pale yellow solid. M+H=457; mp=235.0-236.0° C.
Workup
- customto precipitate
- additionDCM was added until all solids
- dissolutiondissolved
- customa homogenous reaction mixture was obtained
- stirringthe mixture stirred at RT overnight
- washwashed with NaHCO3 (aq) and H2O
- dry with materialdried over MgSO4
- concentrationThe product was concentrated
- washeluted with EtOAc/MeOH
- concentrationconcentrated
Sources & evidence
- ORD record
- ord-8cd215f1e84243eda7cc401c307a2927
- Source dataset
- uspto-grants-2012_04
- Patent number
- US08163906B2
Reaction notes
Loading…